Renewed promise of psychedelics as treatments for mental health disorders

Psychedelic substances may have therapeutic potential for psychiatric disorders, which are the largest cause of disability worldwide.

• Psychedelic compounds such as psilocybin, DMT, LSD, and MDMA are being explored for their potential therapeutic effects.
• Safety concerns associated with these substances are also reviewed.
• The interactive effects of psychedelics combined with psychotherapeutic approaches are discussed.
• The review includes findings from active and recently completed clinical trials.
• Sources include published literature, conference abstracts, and clinical trial registries.

Simplified